Proven results

Clinically demonstrated results with 1 treatment

In 3 clinical studies of people whose frown lines were rated "moderate" or "severe" by a doctor before their treatment with Dysport:

  • 30 days after treatment, in a majority of patients treated with Dysport (55%, 52%, and 60% in each of the 3 studies vs. 0% of patients treated with placebo), the patients and their doctors both thought their frown lines improved by at least 2 grades to a rating of "none" or "mild" at maximum frown.
  • 30 days after treatment, the majority of patients treated with Dysport (88%, 85%, and 86% in each of the 3 studies, vs. 4%, 4%, and 0%, respectively, of patients treated with placebo) had their frown lines rated by a doctor as "none" or "mild" with at least a 1-grade improvement at maximum frown.
  • 30 days after treatment, the majority of patients treated with Dysport (74%, 79%, and 82% in each of the 3 studies, vs. 9%, 1%, and 2%, respectively, of patients treated with placebo) rated their own frown lines as "none" or "mild" with at least a 1-grade improvement at maximum frown.

Used worldwide

Dysport is used for aesthetic purposes in 57 countries. In the United States, Dysport was studied for safety in more than 2,400 U.S. patients, and today over 300,000 women and men have been treated with Dysport.